Chemotherapy-induced Peripheral Neuropathy (CIPN) Examination, Screening and Treatment (1:00:29)

a seminar included in:

COURSE:Core Competencies in Interdisciplinary Cancer Rehabilitation



Chemotherapy-induced peripheral neuropathy (CIPN) is a prevalent side effect of certain commonly-used chemotherapies to treat cancers including breast, colon, and lung, as well as lymphomas. CIPN often reduces the quality of life (QOL) in individuals diagnosed with cancer and is an essential adverse side effect to address because the importance of curing the cancer limits the ability to reduce serious, long-lasting, and even permanent debility that may result from the treatments.

CIPN cannot be prevented, and research has focused on pharmacological therapies aimed at reducing CIPN pain, which unfortunately does not treat the loss of sensation and motor weakness.

This expert-led seminar discusses the need for interprofessional rehabilitation and provides strategies to detect CIPN and apply specific evidence based and targeted therapies for overall management in cancer survivorship. The audience will gain insights on the pathophysiology of CIPN applied specifically to the interprofessional cancer rehabilitation team.

The presenter discusses the impact of systemic chemotherapy specifically as it results in neuropathic pain along with examples of specific drugs and protocols that result in CIPN. She educates the audience how chemotherapy regimens impact distal sensory and motor nerves and addresses autonomic nervous system dysfunction as a result therefore causing impairments for patients during and after treatment.

The presenter further discusses the importance for the entire cancer care team to have a solid understanding of early detection, team resources for triage, and treatment of CIPN. Rehabilitation and integrative movement therapies to manage pain and improve overall function are also discussed with special attention on fall prevention in aging cancer survivors in order to facilitate best overall outcomes and quality of life.


  • Appreciate the incidence and impact of CIPN
  • Learn the types of chemotherapy which cause CIPN
  • Assess CIPN comprehensively
  • Use specific PRO and clinician-based measures
  • Apply evidence-based interventions
  • Advance clinical screening, practice, and research